Kentaro Bandobashi

Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor κB (2008)

Nishioka, Chie, Ikezoe, Takayuki, Yang, Jing, Komatsu, Naoki, Bandobashi, Kentaro, Taniguchi, Ayuko, ...

Idiopathic Hypereosinophilic Syndrome Presenting Acute Abdomen (2007)

Kobayashi, Makoto, Komatsu, Naoki, Kuwayama, Yoshio, Bandobashi, Kentaro, Kubota, Tetsuya, Uemura, Yoshiki, ...

Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells (2007)

Ikezoe, Takayuki, Nishioka, Chie, Bandobashi, Kentaro, Yang, Yang, Kuwayama, Yoshio, Adachi, Yoshihiro, ...

Renal Tuberculosis (Mortar Kidney) (2006)

Miyoshi, Isao, Saito, Tsuyako, Bandobashi, Kentaro, Kuroda, Naoto, Ohtsuki, Yuji, Taguchi, Hirokuni

Concomitant Deposition of Aluminum and Iron in Bone Marrow Trabeculae (2006)

Miyoshi, Isao, Saito, Tsuyako, Bandobashi, Kentaro, Ohtsuki, Yuji, Taguchi, Hirokuni

Papuloerythematous Rash Due to Intralymphatic Cutaneous Metastasis of Cancer (2006)

Miyoshi, Isao, Saito, Tsuyako, Bandobashi, Kentaro, Kodama, Hajime, Ohtsuki, Yuji, Taguchi, Hirokuni

Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo (2005)

Daibata, Masanori, Bandobashi, Kentaro, Kuroda, Masayuki, Imai, Shosuke, Miyoshi, Isao, Taguchi, Hirokuni

Induction of Lytic Epstein-Barr Virus (EBV) Infection by Synergistic Action of Rituximab and Dexamethasone Renders EBV-Positive Lymphoma Cells More Susceptible to Ganciclovir Cytotoxicity In Vitro and In Vivo

Daibata, Masanori, Bandobashi, Kentaro, Kuroda, Masayuki, Imai, Shosuke, Miyoshi, Isao, Taguchi, Hirokuni

The purposeful induction of the lytic form of Epstein-Barr virus (EBV) infection combined with ganciclovir (GCV) treatment has been advocated as a novel strategy for EBV-positive B-cell lymphoma. We...

Induction of Lytic Epstein-Barr Virus (EBV) Infection by Synergistic Action of Rituximab and Dexamethasone Renders EBV-Positive Lymphoma Cells More Susceptible to Ganciclovir Cytotoxicity In Vitro and In Vivo

Daibata, Masanori, Bandobashi, Kentaro, Kuroda, Masayuki, Imai, Shosuke, Miyoshi, Isao, Taguchi, Hirokuni

The purposeful induction of the lytic form of Epstein-Barr virus (EBV) infection combined with ganciclovir (GCV) treatment has been advocated as a novel strategy for EBV-positive B-cell lymphoma. We...